Jianping Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jianping Wang has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Adrian J. Dunn
Department of Psychology, University of Hawaii, Honolulu, HI 96822
1 shared publicationAmanda J. Roberts
Department of Molecular and Integrative Neurosciences, The Scripps Research Institute, La Jolla, CA 92037
1 shared publicationH Zhang
Department of Pharmacology, University of Missouri-Kansas City, Kansas City, MO, USA
1 shared publicationHua Zhang
Department of Pharmacology & Toxicology, University of Missouri-Kansas City School of Pharmacy, Kansas City, MO 64108
1 shared publicationI L Campbell
Department of Pharmacology, University of Missouri-Kansas City, Kansas City, MO, USA
1 shared publicationLi Sun
Department of Pharmacology and Toxicology, School of Pharmacy, University of Missouri-Kansas City, Kansas City, MO 64108, USA
1 shared publication
Latest Publications
- 1 February 2010
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 24 (2) , 220-228
A direct cross-talk between interferon-γ and sonic hedgehog signaling that leads to the proliferation of neuronal precursor cells
- 1 February 2010
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 24 (2) , 220-228
A direct cross-talk between interferon-γ and sonic hedgehog signaling that leads to the proliferation of neuronal precursor cells
- 1 March 2009
- Published by Elsevier in Neuroscience Letters
- Vol. 452 (2) , 96-100
Decreased immobility in swimming test by homologous interferon-α in mice accompanied with increased cerebral tryptophan level and serotonin turnover
- 1 March 2009
- Published by Elsevier in Neuroscience Letters
- Vol. 452 (2) , 96-100
Decreased immobility in swimming test by homologous interferon-α in mice accompanied with increased cerebral tryptophan level and serotonin turnover
- 7 November 2008
- Published by Springer Nature
- p. 71-85
Interferon-α, Molecular Signaling Pathways and Behavior
- 7 November 2008
- Published by Springer Nature
- p. 71-85
Interferon-α, Molecular Signaling Pathways and Behavior
- 8 May 2007
- Published by Springer Nature in Molecular Psychiatry
- Vol. 13 (3) , 293-301
Systemic interferon-α regulates interferon-stimulated genes in the central nervous system
The prime anti-viral cytokine interferon-α (IFN-α) has been implicated in several central nervous system (CNS) disorders in addition to its beneficial effects. Systemic IFN-α treatment causes severe neuropsychiatric complications in humans, including depression, anxiety and cognitive impairments. While numerous neuromodulatory effects by IFN-α have been described, it remains unresolved whether or not systemic IFN-α acts directly on the brain to execute its CNS actions. In the present study, we have analyzed the genes directly regulated in post-IFN-α receptor signaling and found that intraperitoneal administration of mouse IFN-α, but not human IFN-α, activated expression of several prototypic IFN-stimulated genes (ISGs), in particular signal transducers and activators of transcription (STAT1), IFN-induced 15 kDa protein (ISG15), ubiquitin-specific proteinase 18 (USP18) and guanylate-binding protein 3 (GBP3) in the brain. A similar temporal profile for the regulated expression of these IFN-α-activated ISG genes was observed in the brain compared with the peripheral organs. Dual labeling in situ hybridization combined with immunocytochemical staining demonstrated a wide distribution of the key IFN-regulated gene STAT1 transcripts in the different parenchyma cells of the brain, particularly neurons. The overall response to IFN-α challenge was abolished in STAT1 knockout mice. Together, our results indicate a direct, STAT1-dependent action of systemic IFN-α in the CNS, which may provide the basis for a mechanism in humans for neurological/neuropsychiatric illnesses associated with IFN-α therapy.
- 8 May 2007
- Published by Springer Nature in Molecular Psychiatry
- Vol. 13 (3) , 293-301
Systemic interferon-α regulates interferon-stimulated genes in the central nervous system
The prime anti-viral cytokine interferon-α (IFN-α) has been implicated in several central nervous system (CNS) disorders in addition to its beneficial effects. Systemic IFN-α treatment causes severe neuropsychiatric complications in humans, including depression, anxiety and cognitive impairments. While numerous neuromodulatory effects by IFN-α have been described, it remains unresolved whether or not systemic IFN-α acts directly on the brain to execute its CNS actions. In the present study, we have analyzed the genes directly regulated in post-IFN-α receptor signaling and found that intraperitoneal administration of mouse IFN-α, but not human IFN-α, activated expression of several prototypic IFN-stimulated genes (ISGs), in particular signal transducers and activators of transcription (STAT1), IFN-induced 15 kDa protein (ISG15), ubiquitin-specific proteinase 18 (USP18) and guanylate-binding protein 3 (GBP3) in the brain. A similar temporal profile for the regulated expression of these IFN-α-activated ISG genes was observed in the brain compared with the peripheral organs. Dual labeling in situ hybridization combined with immunocytochemical staining demonstrated a wide distribution of the key IFN-regulated gene STAT1 transcripts in the different parenchyma cells of the brain, particularly neurons. The overall response to IFN-α challenge was abolished in STAT1 knockout mice. Together, our results indicate a direct, STAT1-dependent action of systemic IFN-α in the CNS, which may provide the basis for a mechanism in humans for neurological/neuropsychiatric illnesses associated with IFN-α therapy.